248 related articles for article (PubMed ID: 21537470)
1. CARMA3: A novel scaffold protein in regulation of NF-κB activation and diseases.
Sun J
World J Biol Chem; 2010 Dec; 1(12):353-61. PubMed ID: 21537470
[TBL] [Abstract][Full Text] [Related]
2. The CARMA3-Bcl10-MALT1 signalosome promotes angiotensin II-dependent vascular inflammation and atherogenesis.
McAllister-Lucas LM; Jin X; Gu S; Siu K; McDonnell S; Ruland J; Delekta PC; Van Beek M; Lucas PC
J Biol Chem; 2010 Aug; 285(34):25880-4. PubMed ID: 20605784
[TBL] [Abstract][Full Text] [Related]
3. CARMA3 Drives NF-κB Activation and Promotes Intervertebral Disc Degeneration: Involvement of CARMA3-BCL10-MALT1 Signalosome.
Liu Y; Zhang G; Wu J; Meng Y; Hu J; Fu H; Yang D
Inflammation; 2024 Apr; ():. PubMed ID: 38607566
[TBL] [Abstract][Full Text] [Related]
4. CARMA3: Scaffold Protein Involved in NF-κB Signaling.
Zhang S; Lin X
Front Immunol; 2019; 10():176. PubMed ID: 30814996
[TBL] [Abstract][Full Text] [Related]
5. CARMA3 Is a Critical Mediator of G Protein-Coupled Receptor and Receptor Tyrosine Kinase-Driven Solid Tumor Pathogenesis.
McAuley JR; Freeman TJ; Ekambaram P; Lucas PC; McAllister-Lucas LM
Front Immunol; 2018; 9():1887. PubMed ID: 30158935
[TBL] [Abstract][Full Text] [Related]
6. Protein kinase C alpha-CARMA3 signaling axis links Ras to NF-kappa B for lysophosphatidic acid-induced urokinase plasminogen activator expression in ovarian cancer cells.
Mahanivong C; Chen HM; Yee SW; Pan ZK; Dong Z; Huang S
Oncogene; 2008 Feb; 27(9):1273-80. PubMed ID: 17724468
[TBL] [Abstract][Full Text] [Related]
7. Beta-arrestin 2 is required for lysophosphatidic acid-induced NF-kappaB activation.
Sun J; Lin X
Proc Natl Acad Sci U S A; 2008 Nov; 105(44):17085-90. PubMed ID: 18952848
[TBL] [Abstract][Full Text] [Related]
8. CARMA3/Bcl10/MALT1-dependent NF-kappaB activation mediates angiotensin II-responsive inflammatory signaling in nonimmune cells.
McAllister-Lucas LM; Ruland J; Siu K; Jin X; Gu S; Kim DS; Kuffa P; Kohrt D; Mak TW; Nuñez G; Lucas PC
Proc Natl Acad Sci U S A; 2007 Jan; 104(1):139-44. PubMed ID: 17101977
[TBL] [Abstract][Full Text] [Related]
9. The LUBAC participates in lysophosphatidic acid-induced NF-κB activation.
Douanne T; Chapelier S; Rottapel R; Gavard J; Bidère N
Cell Immunol; 2020 Jul; 353():104133. PubMed ID: 32450431
[TBL] [Abstract][Full Text] [Related]
10. CARMA3: A potential therapeutic target in non-cancer diseases.
Gui Z; Zhang Y; Zhang A; Xia W; Jia Z
Front Immunol; 2022; 13():1057980. PubMed ID: 36618379
[TBL] [Abstract][Full Text] [Related]
11. Thrombin-dependent NF-{kappa}B activation and monocyte/endothelial adhesion are mediated by the CARMA3·Bcl10·MALT1 signalosome.
Delekta PC; Apel IJ; Gu S; Siu K; Hattori Y; McAllister-Lucas LM; Lucas PC
J Biol Chem; 2010 Dec; 285(53):41432-42. PubMed ID: 21041303
[TBL] [Abstract][Full Text] [Related]
12. CARMA3 deficiency abrogates G protein-coupled receptor-induced NF-{kappa}B activation.
Grabiner BC; Blonska M; Lin PC; You Y; Wang D; Sun J; Darnay BG; Dong C; Lin X
Genes Dev; 2007 Apr; 21(8):984-96. PubMed ID: 17438001
[TBL] [Abstract][Full Text] [Related]
13. CARD-Bcl10-Malt1 signalosomes: missing link to NF-kappaB.
Wegener E; Krappmann D
Sci STKE; 2007 May; 2007(384):pe21. PubMed ID: 17473310
[TBL] [Abstract][Full Text] [Related]
14. Molecular basis of lysophosphatidic acid-induced NF-κB activation.
Sun W; Yang J
Cell Signal; 2010 Dec; 22(12):1799-803. PubMed ID: 20471472
[TBL] [Abstract][Full Text] [Related]
15. Bcl10 and Malt1 control lysophosphatidic acid-induced NF-kappaB activation and cytokine production.
Klemm S; Zimmermann S; Peschel C; Mak TW; Ruland J
Proc Natl Acad Sci U S A; 2007 Jan; 104(1):134-8. PubMed ID: 17095601
[TBL] [Abstract][Full Text] [Related]
16. CXCL12/SDF-1 alpha activates NF-kappaB and promotes oral cancer invasion through the Carma3/Bcl10/Malt1 complex.
Rehman AO; Wang CY
Int J Oral Sci; 2009 Sep; 1(3):105-18. PubMed ID: 20695076
[TBL] [Abstract][Full Text] [Related]
17. The CBM Complex Underwrites NF-κB Activation to Promote HER2-Associated Tumor Malignancy.
Pan D; Zhu Y; Zhou Z; Wang T; You H; Jiang C; Lin X
Mol Cancer Res; 2016 Jan; 14(1):93-102. PubMed ID: 26392569
[TBL] [Abstract][Full Text] [Related]
18. CARMA3 is crucial for EGFR-Induced activation of NF-κB and tumor progression.
Jiang T; Grabiner B; Zhu Y; Jiang C; Li H; You Y; Lang J; Hung MC; Lin X
Cancer Res; 2011 Mar; 71(6):2183-92. PubMed ID: 21406399
[TBL] [Abstract][Full Text] [Related]
19. Platelet-activating factor-induced NF-kappaB activation and IL-8 production in intestinal epithelial cells are Bcl10-dependent.
Borthakur A; Bhattacharyya S; Alrefai WA; Tobacman JK; Ramaswamy K; Dudeja PK
Inflamm Bowel Dis; 2010 Apr; 16(4):593-603. PubMed ID: 19714753
[TBL] [Abstract][Full Text] [Related]
20. MALT1/paracaspase is a signaling component downstream of CARMA1 and mediates T cell receptor-induced NF-kappaB activation.
Che T; You Y; Wang D; Tanner MJ; Dixit VM; Lin X
J Biol Chem; 2004 Apr; 279(16):15870-6. PubMed ID: 14754896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]